Cofactor-Dependent Regulation of ADAMTS13 Function
Cofactor-Dependent Regulation of ADAMTS13 Function
批准号:
8069919
负责人:
X. Long Zheng
金额:
$36.28万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAffectAffinityAtomic Force MicroscopyBindingBiological AssayBiologyBloodBlood PlateletsCarrier ProteinsCellsCleaved cellCognitionComplexDevelopmentDiseaseElectron MicroscopyEndothelial CellsEndotheliumEnzymesFactor VIIIFactor VIIIaFunctional disorderHemorrhageHemostatic functionIn VitroInheritedInstructionKineticsLaboratoriesLiquid substanceMeasurementMeasuresMediatingMegakaryocytesMembraneMetalloproteasesMolecularOrganellesPaperPeptide HydrolasesPhysiologicalPlasmaPlayPredispositionProcessProteolysisProteolytic ProcessingReactionRegulationResearch PersonnelRoleSiteSolutionsSourceStructureStructure-Activity RelationshipSurface Plasmon ResonanceSyndromeThrombotic Thrombocytopenic Purpurabasecancer procoagulantcofactorin vivoinsightmeetingspreventprogramsshear stresstoolvon Willebrand Diseasevon Willebrand Factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/PrincipalInvestigator(Last, First, Middle): Krishnaswamy, Sliram
PROJECT SUMMARY (See instructions):
Proteolytic cleavage of von Willebrand factor (vWF) by ADAMTS13 metalloprotease is critical for
maintaining normal hemostasis. We hypothesize that factor VI11 (FVIII) may be a cofactorthat markedly
accelerates this processing underflow shear stress. This hypothesis is build upon our findings in vitro and in
vivo as presented in our preliminary results and in recent PNAS paper. However, there are many gaps
between the observed effect and the molecular mechanisms underlying this rate enhancing effect of FVIII
(and activated FVIII). Moreover, the structure-function relationship of FVIII, ADAMTS13 and vWF in this
three-body problem is not fully understood. The aims of this proposal mainly focus on addressing some of
these questions. Specifically, we propose:
1) To establish robust approaches to permit a quantitative description of the action of ADAMTS13 on either
vWF from plasma or UL-vWF newly released from endothelial cells in the absence and presence of FVIII.
This provides information about the magnitude of rate enhancing effect and differential role of FVIII in
proteolytical process of these two sources of substrate.
2) To determine the mechanisms underlying the rate enhancing effect of FVIII (and its derivatives) on
proteolytic cleavage of vWF in solution by ADAMTS13 under shear stress by assessing the contribution of
ternary complex formation between ADAMTS13, vWF and FVIII vs. conformational change of vWF upon
binding of FVIII and/or ADAMTS13 under shear stress to this process.
3) To determine the structural components of ADAMTS13 required for proteolytic cleavage of soluble vWF
and membrane-bound UL-vWF on endothelial cells by focusing on the role of spacer domain and CUB
domains in cognition of vWF and vWF-FVIII complexes under fluid shear stress. Along the same line, we will
determine the domains of ADAMTS13 requried for proteolytic cleavage of membrane bound UL-vWF on
endothelial cells in the absence and presence of shear stress.
RELEVANCE (See instructions):
The information obtained from the proposed study will advance our understanding of biology of vWF
processing by ADAMTS13, pathophysiology of TTP and other thrombotic complications. The results will also
provide more insight into the mechanisms underlying the subtypes of von Willebrand diseases that are
associated with abnormal proteolysis of vWF molecules.
PROJECT/
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of thrombotic microangiopathies
-
批准号:10608740
-
项目类别:
-
资助金额:$51.91万
-
财政年份:2023
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:10200519
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2019
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:10372208
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2019
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:9764787
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2019
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:10231274
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2019
-
负责人:X. Long Zheng
-
依托单位:
Pathogenesis of Thrombotic Microangiopathy
-
批准号:9139498
-
项目类别:
-
资助金额:$45.54万
-
财政年份:2015
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:8504051
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2013
-
负责人:X. Long Zheng
-
依托单位:
Novel Therapeutics for Acquired Thrombotic Thrombocytopenic Purpura
-
批准号:8669155
-
项目类别:
-
资助金额:$41.45万
-
财政年份:2013
-
负责人:X. Long Zheng
-
依托单位:
Cofactor-Dependent Regulation of ADAMTS13 Function
-
批准号:7663368
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2009
-
负责人:X. Long Zheng
-
依托单位:
Structure and Function of ADAMTS13 Metalloprotease
-
批准号:6988488
-
项目类别:
-
资助金额:$32.42万
-
财政年份:2004
-
负责人:X. Long Zheng
-
依托单位:
Structure and Function of ADAMTS13 Metalloprotease
-
批准号:7540945
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:X. Long Zheng
-
依托单位:
Structure and Function of ADAMTS13 Metalloprotease
-
批准号:7152582
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:X. Long Zheng
-
依托单位:
Structure and Function of ADAMTS13 Metalloprotease
-
批准号:7340524
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2004
-
负责人:X. Long Zheng
-
依托单位:
Structure and Function of ADAMTS13 Metalloprotease
-
批准号:6857422
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2004
-
负责人:X. Long Zheng
-
依托单位:
Cofactor-Dependent Regulation of ADAMTS13 Function
-
批准号:8378088
-
项目类别:
-
资助金额:$36.28万
-
财政年份:--
-
负责人:X. Long Zheng
-
依托单位:
Cofactor-Dependent Regulation of ADAMTS13 Function
-
批准号:8450264
-
项目类别:
-
资助金额:$34.54万
-
财政年份:--
-
负责人:X. Long Zheng
-
依托单位:
Cofactor-Dependent Regulation of ADAMTS13 Function
-
批准号:8257876
-
项目类别:
-
资助金额:$36.28万
-
财政年份:--
-
负责人:X. Long Zheng
-
依托单位:
海外基金